ATHENA PHARMACEUTIQUES S.A.S

A French-based multinational dedicated to developing life-cycle products, with a broad range of oral delivery technology platforms focused on modified-release formulations and orodispersible dosage forms, covering therapeutic segments including pain, CNS, cardiometabolic, gastroenterology and gynaecology. Athena Pharmaceutiques operates R&D and manufacturing units at Athena IPS in France and Athena DDS in India, primarily engaged in licensing and supply, providing products in finished form (ODT, tablets, capsules, sachets) or semi-finished form (bulk granules for direct compression, pellets for encapsulation or sachet filling), with facilities approved by EU GMP, Health Canada, TGA Australia, ANVISA, Russia, SAHPRA and other authorities.